CRISPR Gene Editing Ready for Testing in Humans

March 6, 2018

(Financial Times) – Ever since scientists began decoding the human genome in 1990, doctors have dreamt of a new era of medicine where illness could be treated — or even cured — by fxing flaws in a person’s DNA. Rather than using medicine to fight disease, they would be able to hack biology to combat sickness at its source. The dream started to become a reality in 2013, when researchers demonstrated how a gene editing technique, known as Crispr-Cas9, could be used to edit living human cells, raising the possibility that a person’s DNA could be altered much as text is changed by a word-processor. Now, two biotech companies say they plan to start testing the technology in humans as early as this year.

Recommended Reading